Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06645132 · ClinicalTrials.gov registry record · NA
Understanding the Implementation of Cued Exercise Using Wearable Devices and a Custom Smartphone Application Following Bone Marrow Transplant.
A NA study of Blood Cancer and Bone Marrow Transplant (BMT), sponsored by Medical College of Wisconsin.
- Active
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT06645132: Active NA study of Blood Cancer and Bone Marrow Transplant (BMT), sponsored by Medical College of Wisconsin.
NCT06645132 is a NA study of Blood Cancer and Bone Marrow Transplant (BMT) that is active but no longer recruiting, run by Medical College of Wisconsin. The registered enrollment target is 15 participants, below the 264-participant average among 12 other Blood Cancer trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06645132, a NA study of Blood Cancer and Bone Marrow Transplant (BMT), is active but no longer recruiting, sponsored by Medical College of Wisconsin.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to pilot test the feasibility of providing patients diagnosed with a hematologic malignancy, undergoing an allogeneic bone marrow transplant, a wearable device and smartphone app (similar to a Fitbit), that would send personalized reminders to move during their post-transplant inpatient hospital stay to promote physical recovery and well-being.
Primary Outcome
Efficacy will be evaluated by examining the percentage of time participants responded to the cued exercise prompts.
Conditions Studied
Interventions
- BEHAVIORAL exercise intervention
Study Locations (1)
Wisconsin
- Froedtert Hospital - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2024-10-28 |
| Est. Completion | 2025-09 |
| Phase | NA |
What the registry record for NCT06645132 still lists
NCT06645132 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 264-participant average among 12 other Blood Cancer trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Blood Cancer appearing as the primary indexed condition, and to 1 intervention - of which exercise intervention is the first listed.
NCT06645132 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06645132 about?
NCT06645132 is a clinical study titled "Understanding the Implementation of Cued Exercise Using Wearable Devices and a Custom Smartphone Application Following Bone Marrow Transplant.". The purpose of this study is to pilot test the feasibility of providing patients diagnosed with a hematologic malignancy, undergoing an allogeneic bone marrow transplant, a wearable device and smartphone app (similar to a Fitbit), that would send personalized reminders to move during their post-tran...
What is the current status of trial NCT06645132?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2024-10-28. Estimated completion is 2025-09.
What conditions does trial NCT06645132 study?
This clinical trial studies the following conditions: Blood Cancer, Bone Marrow Transplant (BMT).
What interventions are being tested in trial NCT06645132?
The interventions under investigation include: exercise intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06645132?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06645132 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06645132's enrollment target sits among peer trials
15 12th of 12 higher than 1 of 12 other Blood Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Blood Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
RECRUITING · NA
-
Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)
RECRUITING · NA
-
Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy
RECRUITING · NA
-
A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax
RECRUITING · Phase 1
-
Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue
RECRUITING · Phase 2
-
The Leukemia and Lymphoma Society (LLS) National Research Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI